These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 11688840)

  • 1. [Efficiency of cyclosporin A therapy in patients with myelodysplastic syndrome].
    Kokhno AV; Parovichnikova EN; Mikhaĭlova EA; Ustinova EN; Kaplanskaia IB; Dvirnyk VN; Ol'shanskaia IuV; Domracheva EV; Savchenko VG
    Ter Arkh; 2010; 82(8):48-53. PubMed ID: 20873246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune pathology of myelodysplastic syndromes.
    Tomonaga M
    Intern Med; 2001 Oct; 40(10):985-6. PubMed ID: 11688840
    [No Abstract]   [Full Text] [Related]  

  • 3. The immune landscape of myelodysplastic syndromes.
    Fozza C; Crobu V; Isoni MA; Dore F
    Crit Rev Oncol Hematol; 2016 Nov; 107():90-99. PubMed ID: 27823655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of cyclosporine A in myelodysplastic syndrome--review].
    Guan M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):678-80. PubMed ID: 14706160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are T-cell dysfunctions the other side of the moon in the pathogenesis of myelodysplastic syndromes?
    Fozza C; Longinotti M
    Eur J Haematol; 2012 May; 88(5):380-7. PubMed ID: 22296182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The research update on cellular immune abnormality in myelodysplastic syndrome--review].
    Xu F; Liu T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):673-7. PubMed ID: 14706159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging immunosuppressive drugs in myelodysplastic syndromes.
    Epling-Burnette PK; McDaniel J; Wei S; List AF
    Expert Opin Emerg Drugs; 2012 Dec; 17(4):519-41. PubMed ID: 23163589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission of relapsing polychondritis after successful treatment of myelodysplastic syndrome with azacitidine: a case and review of the literature.
    Erden A; Bilgin E; Kılıç L; Sarı A; Armağan B; Büyükaşık Y; Kalyoncu U
    Drug Metab Pers Ther; 2018 Jun; 33(2):105-108. PubMed ID: 29715182
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.